Medical Exoskeleton Market is estimated to grow at a CAGR of 29.4 % during 2022–2027
Posted by kartik joshi on October 10th, 2022
Medical Exoskeleton Market is estimated to grow with a CAGR of 29.4% from 2019-2027. The market is likely to grow due to the advantages of the medical exoskeleton for the rehabilitation purpose, supporting in mobility, and others.
Medical Exoskeletons are used to enhance the physical strength of the human by assisting the limb movements with extra strength. The medical exoskeletons improve the quality of life of the physically disabled people such as patient with spinal cord injury, neurological disorder, paralysis or old age people. Some of the medical human exoskeletons are used by physiotherapy centers and rehabilitation centers, for lower and upper extremity treatment.
Sample Report Copy from Here
The medical exoskeleton is an emerging market in nature with consisting of the good and countable number of players, having considerable revenue in the market. Most of the companies operating in the global medical exoskeleton market are offers medical exoskeleton for the lower and upper limb. The medical exoskeleton offered by the companies offers several benefits that assist disabled people, elderly people to carry out their daily routine and mobility. The medical exoskeleton also assist people working in various industrial sectors.
The most notable market participants are ReWalk Robotics, Ekso Bionics Holdings, Inc., Parker Hannifin Corporation (Indego), CYBERDYNE, INC., Bionik Laboratories Corp., Hocoma AG, Tyromotion GmbH, B-Temia Inc., US Bionics Inc. and Gogoa Mobility Robots among the others have occupied a considerable share of the market owing to their product offerings to the companies.
Market leaders are involved in organic and inorganic growth strategies in the medical exoskeleton market. For instance, the companies have maximized their growth with several organic strategies to enhance the market value and position in the market. The organic developments in the market were maximum among the development in the medical exoskeleton.
The market has experienced several organic strategies such as product launch, product approval and others activities that has resulted positively for the growth of the market. The companies have also conducted inorganic strategies such as agreements, partnership and others that has enhance the product portfolio.
Email Id: firstname.lastname@example.org
Like it? Share it!
About the Authorkartik joshi
Joined: September 27th, 2022
Articles Posted: 141
More by this author